Authors: LO MW TOH J EMMERT SE RITTER MA FURTEK CI LU H COLUCCI WS URETSKY BF RUCINSKA E

Citation: Mw. Lo et al., PHARMACOKINETICS OF INTRAVENOUS AND ORAL LOSARTAN IN PATIENTS WITH HEART-FAILURE, Journal of clinical pharmacology, 38(6), 1998, pp. 525-532

Authors: RITTER MA FURTEK CI LO MW

Citation: Ma. Ritter et al., AN IMPROVED METHOD FOR THE SIMULTANEOUS DETERMINATION OF LOSARTAN ANDITS MAJOR METABOLITE, EXP3174, IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION, Journal of pharmaceutical and biomedical analysis, 15(7), 1997, pp. 1021-1029

Authors: GOLDBERG MR LO MW CHRIST DD CHIOU R FURTEK CI AMIT O CARIDES A BIOLLAZ J PIGUET V NUSSBERGER J BRUNNER HR

Citation: Mr. Goldberg et al., DUP-532, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST - FIRST ADMINISTRATIONAND COMPARISON WITH LOSARTAN, Clinical pharmacology and therapeutics, 61(1), 1997, pp. 59-69

Authors: MCCREA JB LO MW FURTEK CI RITTER MA CARIDES A WALDMAN SA BJORNSSON TD GOLDBERG MR

Citation: Jb. Mccrea et al., KETOCONAZOLE DOES NOT EFFECT THE SYSTEMIC CONVERSION OF LOSARTAN TO E-3174, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 44-44

Authors: SICA DA LO MW SHAW WC KEANE WF GEHR TWB HALSTENSON CE LIPSCHUTZ K FURTEK CI RITTER MA SHAHINFAR S

Citation: Da. Sica et al., THE PHARMACOKINETICS OF LOSARTAN IN RENAL-INSUFFICIENCY, Journal of hypertension, 13, 1995, pp. 49-52

Authors: LO MW GOLDBERG MR MCCREA JB LU H FURTEK CI BJORNSSON TD

Citation: Mw. Lo et al., PHARMACOKINETICS OF LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, AND ITS ACTIVE METABOLITE EXP3174 IN HUMANS, Clinical pharmacology and therapeutics, 58(6), 1995, pp. 641-649